Orpheus Medica is a privately held Canadian biopharmaceutical company leading innovation in discovery, research and development of natural and novel cannabinoid therapeutic agents for pain management and inflammatory conditions through our proprietary drug development platform.
Orpheus’ proprietary drug candidates are screened, selected and optimized against validated molecular targets of interest with preferred bioavailability properties while minimizing off-target interactions and potential toxicity. The objective of Orpheus’ pain management program is to develop a potent, non-psychotropic, local or systemic analgesic for intractable pain that will be safe and well tolerated.
Company Details
- Founded
- -
- Address
- 3403 American Dr, Mississauga,ontario L4v 1t4,canada
- Industry
- Biotechnology
- Website
- http://www.orpheusmed.com
- Keywords
- Charleston.
- HQ
- Mississauga, Ontario
Orpheus Medica Questions
Orpheus Medica's website is http://www.orpheusmed.com
Orpheus Medica's LinkedIn profile is https://ca.linkedin.com/company/orpheus-medica
Orpheus Medica's industry is
Biotechnology
Orpheus Medica's top competitors are
Thinking North,
Realize Ascent Labs, Llc,
Abcelex Technologies Inc.,
Acido Association Of Chartered Industrial Designers Of Ontario,
Lagrangian,
Protégé Biomedical,
Sterilucent, Inc.,
Deep Biologics,
Virotek Biosciences Inc.,
Phygen.
Orpheus Medica's categories are Biotechnology
Orpheus Medica's founding year is 2017
